*|MC:SUBJECT|*
BioRN News October 2022
View this email in your browser

Dear *|FNAME|* *|LNAME|*,


as for most of you, we had a plesantly busy October with a cascade of events, international delegations and conferences.
Let's start with some figures from our Annual Conference on October 7: Two keynotes & Three additional talks, 10 Exhibitors, 7 Young Scientists for one prize, 4.5 h of networking, 1 smoothie-bike, 10l of coffee, 200+ participants. Follow us on the LinkedIn channel on Thursdays for interviews and impressions.
Few days later, the Life Science Investors' Day took place in Heidelberg with 30 Startups and 25+ investors from Europe.
Merck launched its Golden Ticket for BioLabs, offering lab and office space for free for one year for early-stage biotech companies in the field of oncology, neurology & immunology, fertility & women's health.
On the same day, we celebrated with the City of Heidelberg, Zech Stiftung and BioLabs the quick growth of the building that will host from 2023 biotech startups on 2000+ sqm space (Richtfest).

Recently, we have been on the road with DKFZ, Owkin, Sciomics, Singleron and representatives from the Motropole Region Rhine-Neckar to visit the Leuven Ecosystem. It was great to catch up with our partners in Belgium, renewing the mutual interest and strong connections that have been there since more than 10 years.
Simultaneously a group of companies working in personalised medicine came from Canada to connect and looking for cooperation partners in Germany (more). 
Last week during our Lounge, Michaela Arndt shared her journey from bench to bed, from lab to patients and from being a scientist to become an entrepreneur, while building Heidelberg ImmunoTherapeutics.

Networking never stops: check out what we have prepared for November!
 
Annalisa Zuccotti
Events & Communication Lead
BioRN Life Science Cluster Rhine-Neckar
01 | Research Highlights & News
02 | New Members
03 | BioRN Events
04 | Event Calendar & Discounts
05 | Open Positions
01| Research Highlights & News

Apogenix' Asunercept Demonstrates Efficacy in Phase II Trial for the Treatment of Hospitalized COVID-19 Patients [more]

Ascendis Pharma announces Recommended Phase 2 Dose and Cohort Expansion for transcendIT-101, a Phase 1/2 Clinical Trial of TransCon™ TLR7/8 Agonist in Solid Tumors [more]

BioMed X Inks Research Collaboration with Sanofi on Artificial Intelligence for Drug Development [more]

DKFZ:
  • How tumors suppress the development of metastaseses [more]
  • Takeda Oncology Research Award 2022 to Arlou Kristina Angeles [more]
  • A specific inhibitor allows to study an enigmatic enzyme [more]
  • Iron deficiency suppresses important arm of the innate immune system [more]
  • First successful trial for early detection of HPV-related cancer of the pharynx [more]
EMBL:
  • Researchers have combined advanced light microscopy with next-generation sequencing [more]
  • Seeing antibiotics in action inside a pathogenic bacterium [more]

Fraunhofer IGB: Biointelligent sensor for measuring viral activity [more]

Heidelberg University  placed successful in Times Higher Education World University Rankings [more]

KiTZ: New approach to gene therapy for childhood bone and soft tissue cancer [more]

A team of scientists at the Max Planck Institute for Medical Research in Heidelberg has developed new class of light-controllable fluorescent dyes designed for super-resolution microscopy [more]

MetaSystems GmbH collaborates with MLL on AI-based Karyotyping [more]

NCT: Analysis of genetic changes in rare cancers enables early detection of hereditary cancer risk and identifies therapeutic targets [more]

Greener Chemistry with Flow Chemistry at  Raybow PharmaScience [more]

RHEACELL has developed a unique drug based on ABCB5-positive mesenchymal stem cells that helps reprogramme the relevant immune cells and promote healing [more]

Sciomics GmbH: The first step in the journey from imprecise drug therapy to precision medicine - REPO4EU’s Euro / Global Platform for Drug Repurposing [more]
Lab space (630 sqm) available from Jan 2023 in Heidelberg !
Find out more >>

02 | New Members

Ardigen is harnessing advanced Artificial Intelligence methods for novel precision medicine. This company accelerates and reduces the cost of therapy development by providing a broad range of general and specialized digital drug discovery and development services.
Ardigen's general services leverage the capabilities in drug design, protein engineering, and discovery methodologies supported by digital research technologies.

03 | BioRN Events

04 | Event Calendar & Discounts

A Spotlight on Aging - Webinar Series
November 2 & 9 & 16, 2022 - Online >>
 

START UPeritivo
November 3, 2022 - Heidelberg >>
 
07.11.22 BZH LECTURE: Stefan Raunser, MPI Dortmund
November 7, 2022 - Heidelberg >>
 
BioTechX
November 8-10, 2022 - Basel
50% Discount for BioRN members >>

 
Verkauf und Vertrieb für junge Unternehmen
November 9, 2022 - Heidelberg >>
 

Investor Perspective: The Strategic Venturing Spectrum
November 10, 2022 - Hilton Garden Inn Leiden & Online >>
 

PharmaLab-Kongress
November 21-23, 2022 - Düsseldorf >>
 

22.11.22 BZH LECTURE: David Ron, Cambridge
November 22, 2022 - Heidelberg >>
 
Computer-Augmented Molecular Design Enabling Biotech Companies to Accelerate the Drug Discovery Process
November 22, 2022 - Heidelberg >>
 

Career Day Project Management 2022
November 23-25, 2022 - Heidelberg & Online >>
 
BioFIT Event
50% Discount until October 30 with this code: SuppFallOffer_BioFIT22
November 29-30,2022 - Strasbourg, France >>

 
The Spectra Of Life: Dimensional Breadth In Biological Research
EMBL PhD Symposium
December 7-9, 2022 - Heidelberg >>

 

05 | Open Positions


KnowledgeAgent:  Research Analyst (m/w/d) - Life Sciences & Healthcare [more]

HITS:  Medical Data Specialist, Medical Informatics Scientist or Bioinformatician (m/f/d) [more]

WMT:
  • Intern in Medicinal Chemistry [more]
  • Intern in Cell & Molecular Biology [more]
We have partnered with ProcEurope!
What are the benefits for BioRN Members?
  • Significant discounts with Fisher Scientific, an average 44% off list price as well as no delivery, dry ice, hazardous or minimum order charges. 
  • New Suppliers reviewed and brought on board on a regular bases. 
  • No change to processes! ProcEurope negotiate the pricing, but the ordering method stays the same, you order directly with the supplier and liaise with the same sales representative as before.
  • No need to pay ProcEurope's €250 annual fee.

Find out more >>                                                                                      Download
Tweet
Forward
Share

Imprint


Copyright © *|CURRENT_YEAR|* *|LIST:COMPANY|*, All rights reserved.
*|IFNOT:ARCHIVE_PAGE|* *|LIST:DESCRIPTION|*

Responsible for the content:
Dr. Julia Schaft

Editor: Dr. Annalisa Zuccotti

Our mailing address is:
*|HTML:LIST_ADDRESS_HTML|* *|END:IF|*

Commercial Register: Mannheim, HRB 704801
VAT ID: DE 2630 64 014

unsubscribe from this list    update subscription preferences 

*|IF:REWARDS|* *|HTML:REWARDS|* *|END:IF|*